Jobs / United States / Glaxosmithkline LLC
Order to Cash Collection Analyst (US)
Glaxosmithkline LLC · 🇺🇸 Poznan Pastelowa
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles3 certified filings for “AIR & Vaccine Medical Insight Analyst” (Data Scientists) in NC: $107k–$127k, median $127k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. The Order To Cash Collection Analyst supports the end-to-end collections and dispute management process for assigned markets/customers within Order to Cash, ensuring timely customer payments, resolution of disputes and accurate Accounts Receivable positions in line with GSK policies and KPIs. Key Responsibilities: • Manage collections activities for assigned customers/markets - LOCs. • Produce financial reports (i.e Cash Forecasting, Accounts Receivable aging) and review summaries, propose actions for management as required. • Support O2C period end financial closing activities and year-end activities. • Manage customer’s payments and ageing status in ERP / collections tools. • Coordinate with Commercial, Customer Service, Finance and P2P/O2C teams to investigate and resolve disputes; ensure timely answer to queries being raised. • Review Accounts Receivable ageing, high-risk accounts, and overdue balances; propose actions and escalate per O2C escalation matrix. • Prepare periodic reports and commentary on overdue, Days Sales Outstanding (DSO), and dispute drivers for the Collections Lead / O2C Operations Lead. • Work with Cash Application teams to clarify remittances, short-pays, and unallocated cash, ensuring correct posting and clearing of open items. • Resolve queries coming from LOC or customers according to GSK policies and procedures. • Work closely with Local Finance (Stakeholders) in leading O2C deliverables. • Ensure alignment and completion of monthly KPIs. • Follow GSK credit & collections policies, SOX controls, and documentation standards. • Contribute to continuous improvement initiatives related to O2C activities and processes. • Support Management in deliverables and leading projects locally or globally as part of the O2C strategy. Why You? Work arrangement: This role is based in Poland and is hybrid. You will spend regular time onsite for team collaboration and stakeholder meetings. This role supports North American customers and therefore requires a degree of flexibility in working patterns, including periodic participation in shifts aligned to US business hours Basic Qualifications & Skills: We are seeking professionals with the following required skills and qualifications to help us achieve our goals • Degree level or equivalent in Finance, Business, Economics or related discipline (or relevant experience in O2C / finance operations). • 4+ years experience experience in end-to-end O2C operations / Accounts Receivable, with practical exposure to Credit Management, Collections, Disputes and Cash Application in a shared service / hub or LOC environment. • Strong English language skills are fundamental, as you will be supporting the US market • Ability to meet and improving operational KPIs (e.g. past-due %, dispute resolution, cash application timeliness, credit management effectiveness) through data-driven analysis and interventions. • Experience operating within SOP/LSOP and internal control frameworks (e.g. ICFW), including Management Monitoring, c